BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37002743)

  • 1. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
    Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
    Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
    Yu TP; Zhao CC; Chen MY; Lu JX; Li LX; Jia WP
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2398-2402. PubMed ID: 30138983
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and predictors of non-alcoholic fatty liver disease in prediabetes.
    Rajput R; Ahlawat P
    Diabetes Metab Syndr; 2019; 13(5):2957-2960. PubMed ID: 31425963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study.
    Bălănescu A; Bălănescu P; Comănici V; Stan I; Acs B; Prisăcariu L; Brezan F; Ciomârtan T; Gherghina I
    Rom J Intern Med; 2018 Mar; 56(1):47-54. PubMed ID: 29080393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community.
    Onyekwere CA; Ogbera AO; Balogun BO
    Ann Hepatol; 2011; 10(2):119-24. PubMed ID: 21502672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
    Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
    J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
    Bajaj S; Prajapati SK
    J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
    Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
    Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes.
    Karamfilova V; Gateva A; Assyov Y; Nedeva I; Velikova T; Cherkezov N; Mateva L; Kamenov Z
    Metab Syndr Relat Disord; 2020 Nov; 18(9):443-448. PubMed ID: 32780624
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population.
    Lin IT; Lee MY; Wang CW; Wu DW; Chen SC
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey.
    Kotronen A; Yki-Järvinen H; Männistö S; Saarikoski L; Korpi-Hyövälti E; Oksa H; Saltevo J; Saaristo T; Sundvall J; Tuomilehto J; Peltonen M
    BMC Public Health; 2010 May; 10():237. PubMed ID: 20459722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.